Semin Thromb Hemost 2000; Volume 26(Number 01): 101-107
DOI: 10.1055/s-2000-9811
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4663)

Fibrin D-Dimer in Thrombogenic Disorders

Takefumi Matsuo1 , Hiroko Kobayashi1 , Kazuomi Kario2 , Shunji Suzuki1
  • 1Hyogo Prefectural Awaji Hospital, Sumoto, Japan;
  • 2Jichi Medical School, Tochigi, Japan
Further Information

Publication History

Publication Date:
31 December 2000 (online)

 

ABSTRACT

Measurement of D-dimer (fibrin degradation product) is important for determining not only the activation of fibrinolysis but also the severity of a hypercoagulable state. However, fibrin degradation products are in variable, and the reactivity to cross-linked fibrin degradation products produced during fibrin degradation differs depending on the kind of antibody used against D-dimer. In patients with disseminated intravascular coagulation or earthquake-induced mental and physical stress and in patients after percutaneous transluminal coronary angioplasty, all of which are associated with acute fibrin formation and degradation, some discrepancies between two methods of D-dimer detection, automated latex agglutination assay (LPIA) and enzyme-linked immunosorbent assay (Stago), were found. No discrepancies in persistent fibrin formation and degradation were found among the healthy elderly, patients with lacunar stroke, and patients with coronary artery disease, almost all of whom had levels under 5.0 μg/mL, as determined by both methods. Evidence of persistently increased intravascular coagulation and fibrin turnover in patients with atherosclerotic disease was found. The cleavage of cross-linked fibrin by plasmin results in a production of fibrin degradation products, mostly contained D-dimer domains. Although the clinical utility of D-dimer can be achieved by their detection with specific antibodies, measurement of D-dimer as high-molecular-weight fragments may be useful to determine whether patients will undergo further fibrin degradation. When intermediate products of the degradation process need to be assessed, D-dimer level measurement by LPIA may serve as a suitable marker for ongoing fibrinolysis.

REFERENCES

  • 1 Crippa L, D'Angelo S V, Tomassini L. The utility and cost-effectiveness of D-dimer measurements in the diagnosis of deep vein thrombosis.  Haematologica . 1997;  82 446-451
  • 2 Kario K, Matsuo T, Kobayashi H. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay.  Thromb Res . 1992;  66 179-189
  • 3 Kario K, Matsuo T, Kobayashi H. Which factors effect high D-dimer levels in the elderly?.  Thromb Res . 1991;  62 501-508
  • 4 Matsuo T, Nakata H, Kario K. Laboratory diagnosis in coagulofibrinolytic system. In: Tanaka K, ed. Recent Advances in Thrombosis and Fibrinolysis Tokyo: Academic Press, 1991: 243-259
  • 5 Suzuki S, Sakamoto S, Miki T, Matsuo T. Hanshin-Awaji earthquake and acute myocardial infarction.  Lancet . 1995;  345 981
  • 6 Kario K, Matsuo T, Kobayashi H, Yamamoto K, Shimada K. Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: Possible triggering of cardiovascular events after a major earthquake.  J Am Coll Cardiol . 1997;  29 926-933
  • 7 Matsuo T, Suzuki S, Kodama K, Kario K. Hemostatic activation and cardiac events after the 1995 Hanshin-Awaji earthquake.  Int J Haematol . 1998;  67 123-129
  • 8 Hougaku H, Matsumoto M, Kitagawa K. Silent cerebral infarction as a form of hypertensive target organ damage in the brain.  Hypertension . 1992;  20 816-820
  • 9 Trifiletti A, Barbera N, Pizzoleo M A. Haemostatic variables in arterial hypertension.  Haemostasis . 1995;  25 237-240
  • 10 Kario K, Matsuo T, Kobayashi H, Asada R, Matsuo M. ``Silent'' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese.  Arterioscleros Thromb Vasc Biol . 1996;  16 734-741
  • 11 Kario K, Kodama K, Koide M, Matsuo T. Thrombin inhibition in the acute phase of ischeamic stroke using argatroban.  Blood Coag Fibrinolysis . 1995;  6 423-427
  • 12 Lee A J, Gerald F, Fowkes R, Lowe G DO, Rumiley A. Determinants of fibrin D-dimer in the Edinburgh artery study.  Arterioscleros Thromb Vasc Biol . 1995;  15 1094-1097
  • 13 Ring M E, Vecchione J J, Fiore L D. Detection of intracoronary fibrin degradation after coronary balloon angioplasty.  Am J Cardiol . 1991;  67 1330-1334
    >